These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 12932821)

  • 1. Reboxetine modulates norepinephrine efflux in the frontal cortex of the freely moving rat: the involvement of alpha 2 and 5-HT1A receptors.
    Owen JC; Whitton PS
    Neurosci Lett; 2003 Sep; 348(3):171-4. PubMed ID: 12932821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats.
    Dekeyne A; Gobert A; Iob L; Cistarelli L; Melon C; Millan MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):213-8. PubMed ID: 11702096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors.
    Yamaguchi T; Suzuki M; Yamamoto M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):712-20. PubMed ID: 9453456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
    Pallotta M; Segieth J; Whitton PS
    Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex.
    Page ME; Lucki I
    Neuropsychopharmacology; 2002 Aug; 27(2):237-47. PubMed ID: 12093597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the selective norepinephrine reuptake inhibitor reboxetine on norepinephrine and serotonin transmission in the rat hippocampus.
    Szabo ST; Blier P
    Neuropsychopharmacology; 2001 Dec; 25(6):845-57. PubMed ID: 11750178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
    Sacchetti G; Bernini M; Bianchetti A; Parini S; Invernizzi RW; Samanin R
    Br J Pharmacol; 1999 Nov; 128(6):1332-8. PubMed ID: 10578149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reboxetine-induced increase of accumbal dopamine efflux is inhibited by l-propranolol: a microdialysis study with freely moving rats.
    Mizoguchi N; Saigusa T; Aono Y; Sekino R; Takada K; Oi Y; Ueda K; Koshikawa N; Cools AR
    Eur J Pharmacol; 2008 Dec; 601(1-3):94-8. PubMed ID: 18996113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize alpha(2)-adrenoceptors in the prefrontal cortex.
    Invernizzi RW; Parini S; Sacchetti G; Fracasso C; Caccia S; Annoni K; Samanin R
    Br J Pharmacol; 2001 Jan; 132(1):183-8. PubMed ID: 11156576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen on acetylcholine release in frontal cortex of female rats: involvement of serotonergic neuronal systems.
    Matsuda Y; Hirano H; Watanabe Y
    Brain Res; 2002 May; 937(1-2):58-65. PubMed ID: 12020863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade.
    Valentini V; Cacciapaglia F; Frau R; Di Chiara G
    J Neurochem; 2006 Jul; 98(1):113-21. PubMed ID: 16805801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The profiles of interaction of yohimbine with anxiolytic and putative anxiolytic agents to modify 5-HT release in the frontal cortex of freely-moving rats.
    Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1993 Nov; 110(3):1079-84. PubMed ID: 7507776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
    Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism.
    Ortega JE; Fernández-Pastor B; Callado LF; Meana JJ
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):813-22. PubMed ID: 20813509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors.
    Wortley KE; Heal DJ; Stanford SC
    Br J Pharmacol; 1999 Oct; 128(3):659-66. PubMed ID: 10516646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for 5-HT4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine in rat frontal cortex.
    Yamaguchi T; Suzuki M; Yamamoto M
    Brain Res; 1997 Oct; 772(1-2):95-101. PubMed ID: 9406960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The α₁-, but not α₂-, adrenoceptor in the nucleus accumbens plays an inhibitory role upon the accumbal noradrenaline and dopamine efflux of freely moving rats.
    Saigusa T; Aono Y; Uchida T; Takada K; Verheij MM; Koshikawa N; Cools AR
    Eur J Pharmacol; 2012 Aug; 688(1-3):35-41. PubMed ID: 22617026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic reboxetine desensitizes terminal but not somatodendritic alpha2-adrenoceptors controlling noradrenaline release in the rat dorsal hippocampus.
    Parini S; Renoldi G; Battaglia A; Invernizzi RW
    Neuropsychopharmacology; 2005 Jun; 30(6):1048-55. PubMed ID: 15668723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.